# The Human Medicines (Amendment etc.) (EU Exit) Regulations 2020, Paragraph 132


In regulation 165 (omission of regulation 204 (obligation on licensing authority in relation to public announcements))—
(a) in the heading for “Omission” substitute “Amendment”;
(b) for “Omit” substitute “In”;
(c) after “regulation 204” insert “, in paragraph (1), after “pharmacovigilance concerns” insert “which relate to products authorised under a UKMA(NI) or UKMA(UK)”.

---
Source: https://www.legislation.gov.uk/ukdsi/2020/9780348213980/schedule/2/paragraph/132 (the official version)
Page: https://openlegislation.uk/draft-human-medicines-amendment-etc-eu-exit-regulations-2020/schedule-2/paragraph-132
Contains public sector information licensed under the Open Government Licence v3.0. Source: legislation.gov.uk, The National Archives.